title: Transurethral microwave thermotherapy in the treatment of symptomatic benign prostatic hyperplasia.
abstract: One hundred and forty-four patients with symptomatic benign prostatic hyperplasia were treated by transurethral microwave thermotherapy between January and December 1991. Before entering the study, all patients had a Boyarsky symptom score > or = 8, peak flow rate < or = 15 ml/s and postvoiding residual urine < or = 200 ml. Transurethral thermotherapy with the Prostatron (Technomed) was carried out as a single session (60 min) without any analgesia or sedation. Acute urinary retention occurred in 19.4% of the patients after treatment requiring catheterization for 2-3 weeks; morbidity rate was 5.5%. Six months after treatment, Boyarsky symptom score decreased from 11.73 +/- 4.97 to 4.40 +/- 3.21 (mean values +/- SD); peak flow rate increased on average from 8.97 +/- 4.18 to 13.07 +/- 4.87 ml/s and postvoiding residual urine decreased from 135 +/- 17.9 to 63 +/- 34.7 ml. Slight further improvement was shown, in a few patients, at the 1-year follow-up visit.
authors.affiliation: Department of Surgery, L'Aquila University Medical School, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Tubaro
authors.forename: G
authors.initials: G
authors.lastname: Paradiso Galatioto
authors.forename: A
authors.initials: A
authors.lastname: Trucchi
authors.forename: A
authors.initials: A
authors.lastname: Begani
authors.forename: A
authors.initials: A
authors.lastname: Stoppacciaro
authors.forename: E
authors.initials: E
authors.lastname: Trucchi
authors.forename: R
authors.initials: R
authors.lastname: Begani Provinciali
authors.forename: A
authors.initials: A
authors.lastname: Furbetta
authors.forename: C
authors.initials: C
authors.lastname: Laurenti
authors.forename: R
authors.initials: R
authors.lastname: Albanese
mesh_terms: D002404:Catheterization; D005500:Follow-Up Studies; D006801:Humans; D006979:Hyperthermia, Induced / Q000009:adverse effects; D008297:Male; D008872:Microwaves; D009026:Mortality; D011470:Prostatic Hyperplasia / Q000150:complications / Q000473:pathology / Q000628:therapy*; D012044:Regression Analysis; D012984:Software; D014521:Urethra; D016055:Urinary Retention / Q000209:etiology / Q000628:therapy